Is IDEX (IEX) Still Reasonable After A 37% One Year Gain?
IDEX has delivered a solid 37.3% gain over the past year, yet its valuation signals send mixed messages. An intrinsic value estimate suggests roughly 20% upside, while market multiples lean the other way, and a low overall value score points to a stock that does not screen as a clear bargain.
- The 37.3% 1 year return means anyone who held IDEX through the past year has already seen a strong payoff, which raises the bar for fresh buyers looking for further upside from here.
- For IDEX, expectations around the durability of its cash flow generation can support the intrinsic value case, while any pressure on margins or cash conversion remains a key risk that could justify richer trading multiples and limit upside.
- The company scores 2 out of 6 on broader valuation checks, which leans expensive rather than presenting IDEX as an obvious value opportunity.
The issue now is whether IDEX's current share price already reflects most of the cash flow implied by the intrinsic value estimate, or if there is still a reasonable margin between price and value.
Spot opportunities beyond IDEX's mixed valuation signals by screening for 52 high quality undervalued stocks that combine strong cash generation with more attractive pricing.Does IDEX Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) model estimates what IDEX is worth based on the cash it can generate for shareholders. On the latest twelve month figures, IDEX produced about $641.9 million in free cash flow, and the model assumes these cash flows keep growing rather than shrinking. Rolling those projections forward and discounting them back gives an intrinsic value estimate of about $279 per share.
Set against the current share price, that DCF result implies IDEX trades at roughly a 20% discount to the value of its projected cash flows. The key question for you is whether the assumed growth in cash generation is realistic for a mature industrial company, since even small changes to those inputs would meaningfully shift the estimated value.
On this DCF view, IDEX stock currently appears undervalued relative to its projected cash flows.
Our Discounted Cash Flow (DCF) analysis suggests IDEX is undervalued by 20.0%. Track this in your watchlist or portfolio, or discover 52 more high quality undervalued stocks.
Is IDEX Getting Expensive on Earnings?
P/E is a useful yardstick for IDEX because earnings remain a key driver of how investors value established industrial companies. On this metric, IDEX trades on a P/E of about 31.7x. That is close to the peer average of 31.6x in the same Machinery group, yet it is well above the broader industry average of 25.5x.
The fair P/E ratio estimate for IDEX is 23.9x based on factors such as its industry, size and risk profile. Compared with the current 31.7x, the stock trades at a noticeable premium to what this framework suggests would be a more balanced earnings multiple. For you as an investor, that indicates a lot of optimism around IDEX is already embedded in the price, even before considering any further improvement in profitability.
On the P/E test, IDEX stock screens as overvalued relative to what its earnings profile would typically support.
See what the numbers say about this price — find out in our valuation breakdown.
The IDEX Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for IDEX pick up where the valuation puzzle leaves off. They spell out the specific assumptions about IDEX's future growth, margins and earnings that would need to hold for the stock to be worth materially more or less than today's price. They also turn each ratio or model output into a concrete storyline about the future that you can later test against how the business and its share price actually develop. Narratives sit on Simply Wall St's Community page.
You can add your voice to the Simply Wall St community on IDEX by sharing a Narrative that lays out your number driven view on where its growth, margins and execution go from here. Set out your case in one place, then track how it holds up as new results and market reactions come through.
Do you think there's more to the story for IDEX? Head over to our Community to see what others are saying!
The Bottom Line
IDEX offers a split picture. The Discounted Cash Flow (DCF) view points to undervaluation based on its projected cash generation, while the P/E based market multiple suggests the stock is overvalued relative to typical earnings benchmarks. Broader valuation checks remain weak, so the intrinsic value signal comes with a clear health warning. The crux from here is whether IDEX can sustain the cash flows implied by the DCF without needing a reset in margins or the earnings multiple.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com